This interview was conducted with Rasmus Hoffer Le Fevre as FeF Chemical prepared to rebrand to Novo Nordisk Pharmatech. >> Read the article from the September 2015 issue
Podcasts
BioProcess International European Summit 2015 – Speaker Interviews
Listen to exclusive interviews with speakers at the BioProcess International European Summit 2015. Find out more about the program in the March 2015 Special Report.
BPI Revisited: Improving IEX Throughput and Performance with Differentiated Chromatography Sorbents
This podcast features: René Gantier He discusses the changes in the industry since his May 2010 article Improving IEX Throughput and Performance with Differentiated Chromatography Sorbents was published.
BPI Revisited: Increasing Biopharmaceutical Quality Through Packaging Partnerships
This podcast features: Frances DeGrazio
How Pore and Fibrous Interstice Structure Influence Filter Performance
This podcast features: Russell Madsen In this interview with BPI Managing Editor, Mirabel Rios, author Russell Madsen, President of the Williamsburg Group, LLC, provides an update to his two-part article that first appeared in April and May of 2010.
Novel Excipients Prevent Aggregation in Manufacturing and Formulation of Protein and Peptide Therapeutics
This podcast features: Ed Maggio
Recommendations for Extractables and Leachables Testing
This podcast features: Raymond Colton
January 2014 Issue Author Insights
Establishing a Research Agenda in Bioproduction
In an audiocast with managing editor Maribel Rios, Rick Johnston (principal at Bioproduction Group), discusses his views on some changes in the biomanufacturing industry since his January 2008 article, “Establishing a Research Agenda in Bioproduction.” In that article, Johnston reviewed some of the industry’s operational challenges, including the need for supply chain reliability, uncertainty in demand and production processes, and variability in quality assurance and quality control. In the audiocast, he talks about steps the industry has taken toward addressing…
Reviewing Bioindustry’s Economic Year in 2013
This month, managing editor Maribel Rios discusses the financial state of the bioindustry with Howard Levine, founder, president, and principal consultant of BioProcess Technology Consultants. The industry is facing new opportunities for sales growth not only in the United States and Europe, but also in emerging markets such as those in Brazil, Russia, India, and China (the “BRIC” nations). Some of that growth comes from an increasing pipeline of biosimilars driven by the patent expiration of some major blockbuster biotherapies.…